Publications

January 2003 (Revised May 2003)
Case

Heineken NV: Workplace HIV/AIDS Programs in Africa (A)

This case is the first in a three-part series that explores the multifaceted organizational and strategic choices that companies now face as a result of the global AIDS epidemic. Heineken is considering becoming one of the first companies to offer AIDS drugs... View Details

Keywords: Health Disorders; Corporate Social Responsibility and Impact; Employees; Food and Beverage Industry; Africa

2017
Article

Blunted Ambiguity Aversion During Cost-Benefit Decisions in Antisocial Individuals

By: Joshua W. Buckholtz, Uma R. Karmarkar, Shengxuan Ye, Grace M. Brennan and Arielle Baskin-Sommers

Antisocial behavior is often assumed to reflect aberrant risk processing. However, many of the most significant forms of antisocial behavior, including crime, reflect the outcomes of decisions made under conditions of ambiguity rather than risk. While risk and... View Details

Keywords: Ambiguity; Neuroscience; Neuroeconomics; Choice; Psychology; Decision Choice And Uncertainty; Behavior; Decision Choices and Conditions; Cost vs Benefits; Health Disorders

January 2018
Article

The Effect of Cost Sharing on an Employee Weight Loss Program: A Randomized Trial

By: Leslie K. John, Andrea Troxel, William Yancy, Joelle Y. Friedman, Jingsan Zhu, Lin Yang, Robert Galvin, Karen Miller-Kovach, Scott Halpern, George Loewenstein and Kevin Volpp

Purpose: We tested the effects of employer subsidies on employee enrollment, attendance, and weight loss in a nationally-available weight management program.
Design: A randomized trial tested the impact of employer subsidy: 100%; 80% 50% and a hybrid 50% subsidy... View Details

Keywords: Affordable Care Act (ACA); Subsidies; Weight Loss; Obesity; Incentives; Behavioral Economics; Motivation and Incentives; Behavior; Health Disorders; Health Care and Treatment; Compensation and Benefits; United States

Find at Harvard

01 Jun 2017
News

Turning Point: Addiction’s Impact

image by Jeffrey Decoster image by Jeffrey Decoster I was blindsided when my daughter told me, “I’m a heroin addict.” It was November 16, 2009, at a meeting with her drug counselor at Boston College. After I uttered a profanity and slammed my keys on the table, Amy... View Details

Keywords: Melissa Weiksnar (MBA 1982)

23 Jan 2019
News

The Promise of Personalized Medicine

Subscribe on iTunes Subscribe on SoundCloud More Skydeck episodes As a little kid, Rich Horgan (MBA 2018) doesn’t remember thinking much about the differences between himself and his younger brother, Terry. But as he started to get older, he started to ask questions:... View Details

February 2006 (Revised February 2009)
Case

AIDS in Brazil

By: Rohit Deshpande and Ricardo Reisen de Pinho

Abbott Labs has reached an impasse with the Brazilian government in negotiations over the pricing of a new anti-AIDS drug, Kaletra. The Brazilian government threatens compulsory licensing unless Abbott drastically reduces the price of Kaletra. View Details

Keywords: Price; Government and Politics; Health Care and Treatment; Health Disorders; Rights; Negotiation; Business and Government Relations; Pharmaceutical Industry; Brazil

2009
Working Paper

Applying the Care Delivery Value Chain: HIV/AIDS Care in Resource Poor Settings

By: Joseph Rhatigan, Sachin H Jain, Joia S. Mukherjee and Michael E. Porter

The care delivery value chain is a framework that can help conceptualize the organization and structure of care delivery for medical conditions. We apply this framework to HIV/AIDS care in resource-limited settings. Several conclusions arise than can help inform... View Details

Keywords: Customer Value and Value Chain; Framework; Health Care and Treatment; Health Disorders; Service Delivery

September 2006 (Revised July 2012)
Case

PSI India—Will Balbir Pasha Help Fight AIDS? (A)

By: Elie Ofek and Peter Wickersham

In 2002, Population Services International (PSI) was committed to curbing the growing HIV/AIDS epidemic in India. Sanjay Chaganti, program director of HIV/AIDS at PSI India, has to decide on the best communication strategy to achieve this goal. Up to this date most... View Details

Keywords: Advertising Campaigns; Communication Strategy; Health Disorders; Marketing Communications; Social Marketing; Social Enterprise; India

2003
Chapter

La tragédie de la thalidomide: affaires judiciaries et résponses législatives, 1959-1971

By: Arthur A. Daemmrich

Keywords: History; Courts and Trials; Government Legislation; Health Disorders; Pharmaceutical Industry

01 Jun 2013
News

Lab Work

After 16 years at the Australian technology-transfer organization UniQuest, managing director David Henderson (MBA 1989) is moving on to new challenges. Looking back on the experience of shepherding technologies from the university to the marketplace—the... View Details

Keywords: immunology; Ambulatory Health Care Services; Ambulatory Health Care Services

24 Apr 2014
News

Personal crises inform a life’s work

One of the youngest women to attend HBS, Amy Schiffman Langer (MBA 1977) was building a successful investment banking career when a cancer diagnosis at age 29 spurred her to volunteer at the National Alliance of Breast Cancer Organizations. She eventually became the... View Details

08 Feb 2021
News

How Managers Can Support Employees with Chronic Illnesses

April 1989 (Revised January 1994)
Case

Novo Industri

By: Michael E. Porter and Michael J. Enright

Describes the structure of the insulin industry, a treatment for diabetes and Novo's strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to defend and build its international position. Designed as an... View Details

Keywords: Change; Global Strategy; Industry Structures; Alliances; Competitive Strategy; Health Disorders; Pharmaceutical Industry

2009
Working Paper

Where Is the Pharmacy to the World? International Regulatory Variation and Pharmaceutical Industry Location

By: Arthur Daemmrich

A consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater... View Details

Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Health Testing and Trials; Power and Influence; Competitive Strategy; Pharmaceutical Industry; European Union; Germany; United States

31 Jan 2013
News

Ex-Pimco CEO is an engine for charity

Keywords: Religious, Grantmaking, Civic, Professional, and Similar Organizations; Personal Services

June 2024
Supplement

Legacy Partners (B)

By: Richard S. Ruback and Royce Yudkoff

Pre-abstract: Instructors should consider the timing of making videos available to students, as they may reveal key case details.

Abstract: Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six... View Details

January 2023
Case

The END Fund: To Eliminate Neglected Tropical Diseases

By: V. Kasturi Rangan and Courtney Han

Founded in 2012, the END fund focused on eliminating five Neglected Tropical Diseases that accounted for 80% of the tropical diseases affecting nearly 1.5 billion people worldwide. Its roughly $25 million/year annual budget was fully committed when it got news that the... View Details

Keywords: Nonprofit Organizations; Health Disorders; Health Care and Treatment; Resource Allocation; Global Range; Decisions; Investment Funds